Ultraviolet B (UV-B) radiation significantly contributes to skin photoaging, which is characterized by epidermal thickening, collagen degradation, wrinkle formation, barrier dysfunction, and oxidative stress. Nicotinamide mononucleotide (NMN), a key precursor of nicotinamide adenine dinucleotide, regulates cellular energy metabolism and antioxidant defense and demonstrates anti-aging effects in animal models. Here, we investigated the protective effects of oral NMN supplementation against UV-B-induced photoaging in SKH-1 hairless mice. Over a 10-week experimental period, oral NMN administration significantly alleviated epidermal hypertrophy, reduced wrinkle formation and skin surface roughness, improved hydration and elasticity, and restored transepidermal water loss to near-normal levels. Histological analyses revealed marked preservation of collagen fiber density and attenuation of dermal matrix degradation. Furthermore, NMN supplementation inhibited the phosphorylation of MAPK signaling components (ERK, JNK, and p38), suppressed pro-inflammatory cytokine (TNF-α and IL-6) and matrix-degrading enzyme (MMP-1) expression, and restored hyaluronan synthase (HAS-1 and HAS-2) expression. Additionally, NMN enhanced the systemic antioxidant defense, as indicated by the restored superoxide dismutase activity. Thus, NMN has multi-layered protective effects against UV-B–induced skin aging by modulating oxidative stress, inflammatory signaling, extracellular matrix remodeling, and hyaluronic acid metabolism.
As the skin ages, collagen denatures into fragments that accumulate in the dermal matrix. Endo180 allows these fragments to reenter cells and be used for collagen recombination. While several studies have reported on the efficacy of green tea on skin health, studies on black tea have been limited. The aim of this study was to reveal the effects of black tea on skin health and the associated mechanisms. We estimated collagen internalisation using fluorescence-labelled gelatin and measured Endo180 expression following treatment with black tea extract (BTE). BTE at a concentration of 10 ug/ml increased Endo180 mRNA and protein expression by 1.67-fold and 1.46-fold , respectively. In addition, collagen internalisation was increased by 1.29-fold in human skin fibroblasts compared with the untreated control group. These effects were reversed by five inhibitors of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathways to the same levels as those of the untreated control group. These results suggest that BTE enhances collagen internalisation and upregulates Endo180 expression via the MAPK and PI3K/Akt signalling pathways in HDFs and that black tea could be used as a functional food for improving skin health.
Child growth is affected by genetics, nutrition, physical activity, and environmental factors. Despite the improvements in average height among Korean children due to better socioeconomic and nutritional status, safe and effective growth-promoting interventions are still needed for children with mild short stature. This study evaluated the safety and efficacy of fermented oyster extract (FGO) supplementation in children aged 6 to 9 yrs with heights between the third and 25th percentiles for age and gender. In this randomized, double-blind, placebo-controlled trial, subjects received FGO (n = 40) or placebo (n = 40) once daily (500 mg/day) for 24 weeks. This study evaluated the height growth, bone age (BA), growth hormone (GH), insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), and urine deoxypyridinoline (DPD) for the efficacy of FGO and sex hormones, including estradiol, luteinizing hormone, and testosterone, for its safety. Finally, 66 children (33 each in the FGO and placebo group) completed the study. No significant baseline differences existed between the 2 groups. After 24 weeks, the FGO group showed significant improvements in height, height SD score, and height velocity (all P < 0.001). BA and BA delay improved significantly in the FGO group (P = 0.024 and P = 0.035). The FGO group showed significantly greater changes in the IGF-1 and urine DPD levels (P = 0.010 and 0.001, respectively). The GH and IGFBP-3 concentrations increased in the FGO group, but the difference between the two groups was not significant. No serious adverse events or increase in sex hormones were observed after FGO supplementation, assuring its safety. FGO may be a safe and effective health supplement ingredient for height growth in children, irrespective of gender. Future studies will need to evaluate the long-term effects of FGO and its applicability across various populations.